Loading clinical trials...
Loading clinical trials...
Phase II Trial of Weekly Docetaxel and Four Weekly Carboplatin Combination in the First-line Treatment of Advanced Non-small Cell Lung Cancer
Conditions
Interventions
docetaxel and carboplatin
Locations
1
Turkey (Türkiye)
Sanofi-Aventis Administrative Office
Istanbul, Turkey (Türkiye)
Start Date
October 1, 2003
Primary Completion Date
July 1, 2009
Completion Date
July 1, 2009
Last Updated
July 27, 2010
NCT07143110
NCT06885697
NCT04577599
NCT06974604
NCT07035587
NCT04631770
Lead Sponsor
Sanofi
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions